Hyphens Pharma is a speciality pharmaceutical and consumer healthcare group with a direct presence in five ASEAN countries, namely, Singapore, Vietnam, Malaysia, Indonesia, and the Philippines.
The company was incorporated in Dec 2017 as a private company. It sells speciality pharmaceuticals, a proprietary range of dermatological products and health supplement products through Hyphens and Ocean Health Singapore, and medical hypermart and digital supplies.
You can find the prospectus here.
Here Are 5 Quick Things you need to know about the IPO:
1. Hyphens Pharma Profile
The company comprises three main business entities: Hyphen Pharma Pte. Ltd., Pan-Malayan Pharmaceuticals Pte. Ltd. and Ocean Health Pte. Ltd..
Through its wholly-owned subsidiary Pan-Malayan Pharmaceuticals, the company engages in the wholesale of pharmaceuticals and medical supplies in Singapore via both the conventional business model of telesales and sales representatives, as well as an online B2B platform at www.pom.com.sg.